Akoya Biosciences, Inc. provided revenue guidance for the year 2022. The Company, based on its updated plans and initiatives, is raising its full year 2022 revenue guidance range to $73 million to $75 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -1.47% | -12.61% | -58.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.81% | 9.93Cr | |
+7.32% | 22TCr | |
+13.83% | 20TCr | |
+31.33% | 11TCr | |
+3.76% | 6.58TCr | |
+14.64% | 5.27TCr | |
+2.72% | 4.99TCr | |
-5.88% | 3.82TCr | |
+0.25% | 3.54TCr | |
+22.76% | 3.1TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Akoya Biosciences, Inc. Provides Revenue Guidance for the Year 2022